A citation-based method for searching scientific literature

Ling Wang, Qi Wang, Yangchun Xu, Manhua Cui, Liying Han. Curr Drug Targets 2020
Times Cited: 5







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
60


Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib.
Aiste McCormick, Peter Donoghue, Michelle Dixon, Richard O'Sullivan, Rachel L O'Donnell, James Murray, Angelika Kaufmann, Nicola J Curtin, Richard J Edmondson. Clin Cancer Res 2017
39
40

DNA double-strand break repair: from mechanistic understanding to cancer treatment.
Thomas Helleday, Justin Lo, Dik C van Gent, Bevin P Engelward. DNA Repair (Amst) 2007
420
40

Integrated genomic characterization of endometrial carcinoma.
Cyriac Kandoth, Nikolaus Schultz, Andrew D Cherniack, Rehan Akbani, Yuexin Liu, Hui Shen, A Gordon Robertson, Itai Pashtan, Ronglai Shen, Christopher C Benz,[...]. Nature 2013
40

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
40

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
957
40

Targeting the tumour microenvironment in ovarian cancer.
Jean M Hansen, Robert L Coleman, Anil K Sood. Eur J Cancer 2016
66
40

Mucinous Ovarian Carcinoma.
Allan Hackshaw, David Gershenson, Jonathan Ledermann. N Engl J Med 2019
2
100

A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation.
Qi Yang, William W Du, Nan Wu, Weining Yang, Faryal Mehwish Awan, Ling Fang, Jian Ma, Xiangmin Li, Yan Zeng, Zhenguo Yang,[...]. Cell Death Differ 2017
163
40

High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs.
Sven Rottenberg, Janneke E Jaspers, Ariena Kersbergen, Eline van der Burg, Anders O H Nygren, Serge A L Zander, Patrick W B Derksen, Michiel de Bruin, John Zevenhoven, Alan Lau,[...]. Proc Natl Acad Sci U S A 2008
615
20


Automated synthesis of PET radiotracers by copper-mediated 18 F-fluorination of organoborons: Importance of the order of addition and competing protodeborylation.
Andrew V Mossine, Allen F Brooks, Vadim Bernard-Gauthier, Justin J Bailey, Naoko Ichiishi, Ralf Schirrmacher, Melanie S Sanford, Peter J H Scott. J Labelled Comp Radiopharm 2018
19
20

Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatin.
Trevor Hay, James R Matthews, Lucie Pietzka, Alan Lau, Aaron Cranston, Anders O H Nygren, Anthony Douglas-Jones, Graeme C M Smith, Niall M B Martin, Mark O'Connor,[...]. Cancer Res 2009
91
20

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
20

[(18)F]FluorThanatrace uptake as a marker of PARP1 expression and activity in breast cancer.
Christine E Edmonds, Mehran Makvandi, Brian P Lieberman, Kuiying Xu, Chenbo Zeng, Shihong Li, Catherine Hou, Hsiaoju Lee, Roger A Greenberg, David A Mankoff,[...]. Am J Nucl Med Mol Imaging 2016
25
20

Non-invasive PET Imaging of PARP1 Expression in Glioblastoma Models.
Brandon Carney, Giuseppe Carlucci, Beatriz Salinas, Valentina Di Gialleonardo, Susanne Kossatz, Axel Vansteene, Valerie A Longo, Alexander Bolaender, Gabriela Chiosis, Kayvan R Keshari,[...]. Mol Imaging Biol 2016
39
20

An Overview of PET Radiochemistry, Part 1: The Covalent Labels 18F, 11C, and 13N.
Verena Pichler, Neydher Berroterán-Infante, Cecile Philippe, Chrysoula Vraka, Eva-Maria Klebermass, Theresa Balber, Sarah Pfaff, Lukas Nics, Markus Mitterhauser, Wolfgang Wadsak. J Nucl Med 2018
11
20

Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy.
Jean-Rémy Marchand, Andrea Carotti, Daniela Passeri, Paolo Filipponi, Paride Liscio, Emidio Camaioni, Roberto Pellicciari, Antimo Gioiello, Antonio Macchiarulo. Biochim Biophys Acta 2014
9
20


Synthesis and evaluation of an AZD2461 [18F]PET probe in non-human primates reveals the PARP-1 inhibitor to be non-blood-brain barrier penetrant.
Sean W Reilly, Laura N Puentes, Alexander Schmitz, Chia-Ju Hsieh, Chi-Chang Weng, Catherine Hou, Shihong Li, Yin-Ming Kuo, Prashanth Padakanti, Hsiaoju Lee,[...]. Bioorg Chem 2019
5
20

An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions.
Maeve A Lowery, David P Kelsen, Zsofia K Stadler, Kenneth H Yu, Yelena Y Janjigian, Emmy Ludwig, David R D'Adamo, Erin Salo-Mullen, Mark E Robson, Peter J Allen,[...]. Oncologist 2011
158
20


Target engagement imaging of PARP inhibitors in small-cell lung cancer.
Brandon Carney, Susanne Kossatz, Benjamin H Lok, Valentina Schneeberger, Kishore K Gangangari, Naga Vara Kishore Pillarsetty, Wolfgang A Weber, Charles M Rudin, John T Poirier, Thomas Reiner. Nat Commun 2018
41
20

Dual-Modality Optical/PET Imaging of PARP1 in Glioblastoma.
Giuseppe Carlucci, Brandon Carney, Christian Brand, Susanne Kossatz, Christopher P Irwin, Sean D Carlin, Edmund J Keliher, Wolfgang Weber, Thomas Reiner. Mol Imaging Biol 2015
38
20

Imaging the DNA damage response with PET and SPECT.
James C Knight, Sofia Koustoulidou, Bart Cornelissen. Eur J Nucl Med Mol Imaging 2017
27
20

The DNA damage response and cancer therapy.
Christopher J Lord, Alan Ashworth. Nature 2012
923
20

PET Imaging of PARP Expression Using 18F-Olaparib.
Thomas C Wilson, Mary-Ann Xavier, James Knight, Stefan Verhoog, Julia Baguña Torres, Michael Mosley, Samantha L Hopkins, Sheena Wallington, Phillip D Allen, Veerle Kersemans,[...]. J Nucl Med 2019
27
20

Derisking the Cu-Mediated 18F-Fluorination of Heterocyclic Positron Emission Tomography Radioligands.
Nicholas J Taylor, Enrico Emer, Sean Preshlock, Michael Schedler, Matthew Tredwell, Stefan Verhoog, Joel Mercier, Christophe Genicot, Véronique Gouverneur. J Am Chem Soc 2017
71
20

The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models.
Lenka Oplustil O'Connor, Stuart L Rulten, Aaron N Cranston, Rajesh Odedra, Henry Brown, Janneke E Jaspers, Louise Jones, Charlotte Knights, Bastiaan Evers, Attilla Ting,[...]. Cancer Res 2016
42
20

Targeting the DNA Damage Response in Cancer.
Mark J O'Connor. Mol Cell 2015
604
20

PARPi-FL--a fluorescent PARP1 inhibitor for glioblastoma imaging.
Christopher P Irwin, Yasiri Portorreal, Christian Brand, Yachao Zhang, Pooja Desai, Beatriz Salinas, Wolfgang A Weber, Thomas Reiner. Neoplasia 2014
35
20

A general copper-mediated nucleophilic 18F fluorination of arenes.
Matthew Tredwell, Sean M Preshlock, Nicholas J Taylor, Stefan Gruber, Mickael Huiban, Jan Passchier, Joël Mercier, Christophe Génicot, Véronique Gouverneur. Angew Chem Int Ed Engl 2014
168
20

Molecular Imaging of PARP.
Brandon Carney, Susanne Kossatz, Thomas Reiner. J Nucl Med 2017
44
20

Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.
Junko Murai, Shar-yin N Huang, Benu Brata Das, Amelie Renaud, Yiping Zhang, James H Doroshow, Jiuping Ji, Shunichi Takeda, Yves Pommier. Cancer Res 2012
981
20

A PET imaging agent for evaluating PARP-1 expression in ovarian cancer.
Mehran Makvandi, Austin Pantel, Lauren Schwartz, Erin Schubert, Kuiying Xu, Chia-Ju Hsieh, Catherine Hou, Hyoung Kim, Chi-Chang Weng, Harrison Winters,[...]. J Clin Invest 2018
50
20

Imaging therapeutic PARP inhibition in vivo through bioorthogonally developed companion imaging agents.
Thomas Reiner, Jessica Lacy, Edmund J Keliher, Katherine S Yang, Adeeti Ullal, Rainer H Kohler, Claudio Vinegoni, Ralph Weissleder. Neoplasia 2012
68
20

Preliminary evaluation of a novel 18F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer.
Dong Zhou, Jinbin Xu, Cedric Mpoy, Wenhua Chu, Sung Hoon Kim, Huifangjie Li, Buck E Rogers, John A Katzenellenbogen. Nucl Med Biol 2018
12
20

An 18F-Labeled Poly(ADP-ribose) Polymerase Positron Emission Tomography Imaging Agent.
Filip Zmuda, Adele Blair, Maria Clara Liuzzi, Gaurav Malviya, Anthony J Chalmers, David Lewis, Andrew Sutherland, Sally L Pimlott. J Med Chem 2018
11
20

Up-regulation of miR-1245 by c-myc targets BRCA2 and impairs DNA repair.
Libing Song, Ting Dai, Yingjun Xie, Chanjuan Wang, Chuyong Lin, Zhiqiang Wu, Zhe Ying, Jueheng Wu, Mengfeng Li, Jun Li. J Mol Cell Biol 2012
34
20

Domain-specific phosphomimetic mutation allows dissection of different protein kinase C (PKC) isotype-triggered activities of the RNA binding protein HuR.
Sebastian Schulz, Anke Doller, Nicole R Pendini, Jacqueline A Wilce, Josef Pfeilschifter, Wolfgang Eberhardt. Cell Signal 2013
22
20

Epigenetic changes in BRCA1-mutated familial breast cancer.
Bradley Downs, San Ming Wang. Cancer Genet 2015
8
20

Cellular senescence in ionizing radiation (Review).
Zhengting Chen, Ke Cao, Yaoxiong Xia, Yunfen Li, Yu Hou, Li Wang, Lan Li, Li Chang, Wenhui Li. Oncol Rep 2019
7
20

MiR-203 acts as a radiosensitizer of gastric cancer cells by directly targeting ZEB1.
Ying Jiang, Shan Jin, Shisheng Tan, Qi Shen, Yingbo Xue. Onco Targets Ther 2019
12
20

Role of DNA damage response pathways in preventing carcinogenesis caused by intrinsic replication stress.
M D Wallace, T L Southard, K J Schimenti, J C Schimenti. Oncogene 2014
16
20



Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity.
Jen-Wei Huang, Yemin Wang, Kiranjit K Dhillon, Philamer Calses, Emily Villegas, Patrick S Mitchell, Muneesh Tewari, Christopher J Kemp, Toshiyasu Taniguchi. Mol Cancer Res 2013
67
20

Opposite modifying effects of HR and NHEJ deficiency on cancer risk in Ptc1 heterozygous mouse cerebellum.
M Tanori, E Pasquali, S Leonardi, P Giardullo, V Di Majo, G Taccioli, J Essers, R Kanaar, L H Mullenders, M J Atkinson,[...]. Oncogene 2011
8
20

NBS1 is regulated by two kind of mechanisms: ATM-dependent complex formation with MRE11 and RAD50, and cell cycle-dependent degradation of protein.
Hui Zhou, Kasumi Kawamura, Hiromi Yanagihara, Junya Kobayashi, Qiu-Mei Zhang-Akiyama. J Radiat Res 2017
9
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.